Sanofi (SNYNF)
85.51
0.00 (0.00%)
USD |
OTCM |
Sep 15, 16:00
Sanofi Enterprise Value : 113.03B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 113.03B |
| September 14, 2026 | 113.03B |
| September 11, 2026 | 111.23B |
| September 10, 2026 | 115.23B |
| September 09, 2026 | 112.44B |
| September 08, 2026 | 114.97B |
| September 04, 2026 | 117.61B |
| September 03, 2026 | 117.61B |
| September 02, 2026 | 116.44B |
| September 01, 2026 | 118.61B |
| August 31, 2026 | 118.76B |
| August 28, 2026 | 119.83B |
| August 27, 2026 | 118.09B |
| August 26, 2026 | 118.09B |
| August 25, 2026 | 121.57B |
| August 24, 2026 | 121.57B |
| August 21, 2026 | 122.68B |
| August 20, 2026 | 119.14B |
| August 19, 2026 | 119.14B |
| August 18, 2026 | 118.50B |
| August 17, 2026 | 114.77B |
| August 14, 2026 | 116.18B |
| August 13, 2026 | 114.97B |
| August 12, 2026 | 114.97B |
| August 11, 2026 | 114.91B |
| Date | Value |
|---|---|
| August 10, 2026 | 113.45B |
| August 07, 2026 | 116.57B |
| August 06, 2026 | 115.21B |
| August 05, 2026 | 110.11B |
| August 04, 2026 | 110.11B |
| August 03, 2026 | 110.98B |
| July 31, 2026 | 111.04B |
| July 30, 2026 | 109.88B |
| July 29, 2026 | 119.47B |
| July 28, 2026 | 117.47B |
| July 27, 2026 | 116.67B |
| July 24, 2026 | 116.40B |
| July 23, 2026 | 116.40B |
| July 22, 2026 | 113.03B |
| July 21, 2026 | 116.06B |
| July 20, 2026 | 116.83B |
| July 17, 2026 | 114.85B |
| July 16, 2026 | 114.85B |
| July 15, 2026 | 114.85B |
| July 14, 2026 | 111.84B |
| July 13, 2026 | 114.20B |
| July 10, 2026 | 116.49B |
| July 09, 2026 | 115.39B |
| July 08, 2026 | 110.20B |
| July 07, 2026 | 112.72B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 528.30B |
| GSK Plc | 120.62B |
| Novartis AG | 295.48B |
| Pfizer Inc. | 208.80B |
| Roche Holding AG | -- |
Enterprise Value Related Metrics
| Earnings Yield | 4.54% |
| Operating Earnings Yield | 14.06% |
| Normalized Earnings Yield | 8.036 |